share_log

Craig-Hallum Initiates Coverage On MaxCyte With Buy Rating, Announces Price Target of $7

Benzinga ·  Nov 29, 2023 11:10

Craig-Hallum analyst Matt Hewitt initiates coverage on MaxCyte (NASDAQ:MXCT) with a Buy rating and announces Price Target of $7.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment